
Customer experience solutions provider Concentrix (NASDAQ: CNXC) met Wall Street’s revenue expectations in Q2 CY2026, with sales up 1.9% year on year to $2.46 billion. On the other hand, next quarter’s revenue guidance of $2.48 billion was less impressive, coming in 2.4% below analysts’ estimates. Its non-GAAP profit of $2.63 per share was in line with analysts’ consensus estimates.
Is now the time to buy Concentrix? Find out by accessing our full research report, it’s free.
Concentrix (CNXC) Q2 CY2026 Highlights:
- Revenue: $2.46 billion vs analyst estimates of $2.47 billion (1.9% year-on-year growth, in line)
- Adjusted EPS: $2.63 vs analyst estimates of $2.63 (in line)
- Adjusted EBITDA: $347.4 million vs analyst estimates of $352.6 million (14.1% margin, 1.5% miss)
- The company dropped its revenue guidance for the full year to $9.98 billion at the midpoint from $10.11 billion, a 1.3% decrease
- Management lowered its full-year Adjusted EPS guidance to $11.00 at the midpoint, a 6.5% decrease
- Operating Margin: 3.9%, down from 6.1% in the same quarter last year
- Free Cash Flow Margin: 8.5%, up from 7.5% in the same quarter last year
- Market Capitalization: $1.60 billion
“Our second quarter marked an acceleration in many areas in the evolution of our business,” said Chris Caldwell, President and CEO of Concentrix.
Company Overview
With a team of approximately 450,000 employees across 75 countries, Concentrix (NASDAQ: CNXC) designs and delivers customer experience solutions that help global brands manage their customer interactions across digital channels and contact centers.
Revenue Growth
A company’s long-term performance is an indicator of its overall quality. Any business can put up a good quarter or two, but the best consistently grow over the long haul.
With $10.00 billion in revenue over the past 12 months, Concentrix is one of the larger companies in the business services industry and benefits from a well-known brand that influences purchasing decisions.
As you can see below, Concentrix grew its sales at an exceptional 14% compounded annual growth rate over the last five years. This is an encouraging starting point for our analysis because it shows Concentrix’s demand was higher than many business services companies.

Long-term growth is the most important, but within business services, a half-decade historical view may miss new innovations or demand cycles. Concentrix’s annualized revenue growth of 7.5% over the last two years is below its five-year trend, but we still think the results suggest healthy demand. 
This quarter, Concentrix grew its revenue by 1.9% year on year, and its $2.46 billion of revenue was in line with Wall Street’s estimates. Company management is currently guiding for flat sales next quarter.
Looking further ahead, sell-side analysts expect revenue to grow 2% over the next 12 months, a deceleration versus the last two years. This projection doesn’t excite us and suggests its products and services will face some demand challenges. At least the company is tracking well in other measures of financial health.
WHILE YOU’RE HERE: The Next Palantir? One satellite company captures images of every point on Earth. Every single day. The Pentagon wants it. Hedge funds are using it to beat earnings. You’ve probably never heard of it.
This is what the early days of Palantir looked like before it became a $437 billion giant. Same playbook. Different technology. If you missed Palantir, you need to see this. Claim The Stock Ticker for Free HERE.
Adjusted Operating Margin
Concentrix has managed its cost base well over the last five years. It demonstrated solid profitability for a business services business, producing an average adjusted operating margin of 13.4%.
Looking at the trend in its profitability, Concentrix’s adjusted operating margin decreased by 1.2 percentage points over the last five years. This raises questions about the company’s expense base because its revenue growth should have given it leverage on its fixed costs, resulting in better economies of scale and profitability.

This quarter, Concentrix generated an adjusted operating margin profit margin of 11.9%, in line with the same quarter last year. This indicates the company’s overall cost structure has been relatively stable.
Earnings Per Share
We track the long-term change in earnings per share (EPS) for the same reason as long-term revenue growth. Compared to revenue, however, EPS highlights whether a company’s growth is profitable.
Concentrix’s EPS grew at an unimpressive 4% compounded annual growth rate over the last five years, lower than its 14% annualized revenue growth. This tells us the company became less profitable on a per-share basis as it expanded.

We can take a deeper look into Concentrix’s earnings to better understand the drivers of its performance. As we mentioned earlier, Concentrix’s adjusted operating margin was flat this quarter but declined by 1.2 percentage points over the last five years. Its share count also grew by 17%, meaning the company not only became less efficient with its operating expenses but also diluted its shareholders. 
Like with revenue, we analyze EPS over a shorter period to see if we are missing a change in the business.
For Concentrix, its two-year annual EPS declines of 1.6% show it’s continued to underperform. These results were bad no matter how you slice the data.
In Q2, Concentrix reported adjusted EPS of $2.63, down from $2.70 in the same quarter last year. This print was close to analysts’ estimates. Over the next 12 months, Wall Street expects Concentrix’s full-year EPS to grow 15% from $10.97 to $12.62.
Key Takeaways from Concentrix’s Q2 Results
We struggled to find many positives in these results. Its full-year EPS guidance missed and its EPS guidance for next quarter fell short of Wall Street’s estimates. Overall, this quarter could have been better. The stock traded down 24% to $19.17 immediately after reporting.
Concentrix didn’t show it’s best hand this quarter, but does that create an opportunity to buy the stock right now? What happened in the latest quarter matters, but not as much as longer-term business quality and valuation, when deciding whether to invest in this stock. We cover that in our actionable full research report which you can read here (it’s free).
